Perioperative SGLT2 inhibitors and renal protection: should they be withheld in all patients or continued in selected cases? That may be the question
An analysis of the potential renoprotective benefits of SGLT2 inhibitors in the perioperative setting of cardiac surgery and the possible advantages of avoiding their routine preoperative discontinuation.